With over twenty-five years of experience in biopharmaceutical Regulatory Affairs, Susie joined GeoVax in 2024. Having held prior leadership roles with Vaxxinity, Takeda, Novavax, Parexel, and Human Genome Sciences, Susie brings a broad view across the regulatory landscape and has experience in regulatory strategy development, global submission management, regulatory oversight of clinical trials, and the direct interaction with US and International Health Authorities related to submissions, inspections and reporting. Susie received her MS in Regulatory Science from Johns Hopkins University and is RAC certified.